Nuvation Bio Inc. (NUVB) Misses Q2 EPS by 3c

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $31.69 million versus the consensus estimate of $26.69 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• ACRES Commercial Realty says labor dispute is hindering hotel sale
• Bessent on Iran: maximum economic pressure means likely not a kinetic restart